Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michio Kosugi

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
The Journal of Biological Chemistry|February 10, 2012
MUC1-C oncoprotein induces TCF7L2 transcription factor activation and promotes cyclin D1 expression in human breast cancer cellsHasan Rajabi, Rehan Ahmad, Caining Jin, et al.
Molecular Pharmacology|May 7, 2010
Survival of human multiple myeloma cells is dependent on MUC1 C-terminal transmembrane subunit oncoprotein functionLi Yin, Rehan Ahmad, Michio Kosugi, et al.
International Journal of Clinical Oncology|January 8, 2021
Distribution analysis of hydrogel spacer and evaluation of rectal dose reduction in Japanese prostate cancer patients undergoing stereotactic body radiation therapyHiroaki Kobayashi, Takahisa Eriguchi, Tomoki Tanaka, et al.
Hinyokika Kiyo. Acta Urologica Japonica|August 14, 2009
[Primary small cell carcinoma of the ureter: a case report]Hiroki Ito, Kiichiro Kodaira, Michio Kosugi, et al.
BMJ Open|November 25, 2021
Vasohibin-1 expression as a biomarker of aggressive nature in ductal adenocarcinoma of the prostate: a retrospective cohort study at two centres in JapanHiroaki Kobayashi, Takeo Kosaka, Shuji Mikami, et al.
Cancer Biology & Therapy|July 2, 2010
Terminal differentiation of chronic myelogenous leukemia cells is induced by targeting of the MUC1-C oncoproteinLi Yin, Rehan Ahmad, Michio Kosugi, et al.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|December 13, 2006
[Influence of androgen deprivation therapy on prostate volume in patients with prostate cancer undergoing prostate brachytherapy with permanent seed implantation]Ryuichi Mizuno, Tetsuo Monma, Masanori Hasegawa, et al.
Brachytherapy|October 26, 2007
Comparison of intraoperative ultrasound with postimplant computed tomography--dosimetric values at Day 1 and Day 30 after prostate brachytherapyToshio Ohashi, Atsunori Yorozu, Kazuhito Toya, et al.
Science Signaling|February 18, 2011
MUC1-C oncoprotein promotes STAT3 activation in an autoinductive regulatory loopRehan Ahmad, Hasan Rajabi, Michio Kosugi, et al.
Japanese Journal of Radiology|November 6, 2023
An optimal method of hydrogel spacer insertion for stereotactic body radiation therapy of prostate cancerHiroaki Kobayashi, Takahisa Eriguchi, Tomoki Tanaka, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
The Journal of Biological Chemistry|February 10, 2012
MUC1-C oncoprotein induces TCF7L2 transcription factor activation and promotes cyclin D1 expression in human breast cancer cellsHasan Rajabi, Rehan Ahmad, Caining Jin, et al.
Molecular Pharmacology|May 7, 2010
Survival of human multiple myeloma cells is dependent on MUC1 C-terminal transmembrane subunit oncoprotein functionLi Yin, Rehan Ahmad, Michio Kosugi, et al.
International Journal of Clinical Oncology|January 8, 2021
Distribution analysis of hydrogel spacer and evaluation of rectal dose reduction in Japanese prostate cancer patients undergoing stereotactic body radiation therapyHiroaki Kobayashi, Takahisa Eriguchi, Tomoki Tanaka, et al.
Hinyokika Kiyo. Acta Urologica Japonica|August 14, 2009
[Primary small cell carcinoma of the ureter: a case report]Hiroki Ito, Kiichiro Kodaira, Michio Kosugi, et al.
BMJ Open|November 25, 2021
Vasohibin-1 expression as a biomarker of aggressive nature in ductal adenocarcinoma of the prostate: a retrospective cohort study at two centres in JapanHiroaki Kobayashi, Takeo Kosaka, Shuji Mikami, et al.
Cancer Biology & Therapy|July 2, 2010
Terminal differentiation of chronic myelogenous leukemia cells is induced by targeting of the MUC1-C oncoproteinLi Yin, Rehan Ahmad, Michio Kosugi, et al.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|December 13, 2006
[Influence of androgen deprivation therapy on prostate volume in patients with prostate cancer undergoing prostate brachytherapy with permanent seed implantation]Ryuichi Mizuno, Tetsuo Monma, Masanori Hasegawa, et al.
Brachytherapy|October 26, 2007
Comparison of intraoperative ultrasound with postimplant computed tomography--dosimetric values at Day 1 and Day 30 after prostate brachytherapyToshio Ohashi, Atsunori Yorozu, Kazuhito Toya, et al.
Science Signaling|February 18, 2011
MUC1-C oncoprotein promotes STAT3 activation in an autoinductive regulatory loopRehan Ahmad, Hasan Rajabi, Michio Kosugi, et al.
Japanese Journal of Radiology|November 6, 2023
An optimal method of hydrogel spacer insertion for stereotactic body radiation therapy of prostate cancerHiroaki Kobayashi, Takahisa Eriguchi, Tomoki Tanaka, et al.
Pageof 3